Effects of Angiotensin Receptor-Neprilysin Inhibitors Versus Enalapril or Valsartan on Patients With Heart Failure: A Systematic Review and Meta-Analysis

Recent studies have focused on treating heart failure, primarily mitigating symptoms and reducing the risk of mortality and other cardiovascular complications. A promising new treatment approach involves using LCZ696, an angiotensin receptor-neprilysin inhibitor (ARNI) comprising sacubitril and vals...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Arpit, Meyur, Shourya, Wadhwa, Lovish, Singh, Kamaldeep, Sharma, Rishi, Panchal, Ishita, Varrassi, Giustino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405977/
https://www.ncbi.nlm.nih.gov/pubmed/37554618
http://dx.doi.org/10.7759/cureus.41566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405977/
https://www.ncbi.nlm.nih.gov/pubmed/37554618
http://dx.doi.org/10.7759/cureus.41566

Ejemplares similares